Estimated Effectiveness of 2024-2025 COVID-19 Vaccines in Adults Key Points Question What was the effectiveness of 2024-2025 COVID-19 vaccines against medically attended COVID-19 among adults 18 years and older in the US?
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Thomas Duszynski
Interim Estimated Effectiveness of 2025-2026 COVID-19 Vaccines in Adults Using a Test-Negative Design
|
By Ryan Wiegand, Sean Chickery, Duck-Hye Yang, Malini DeSilva, Kristin Dascomb, Stephanie A. Irving, Karthik Natarajan, Nicola P. Klein, Shaun Grannis, Toan C Ong, Elizabeth Rowley, Adam Yates, Yan Zhuang Verified, Charlene E. McEvoy, Omobosola Akinsete, Allison L. Naleway, Padma Koppolu, Ousseny Zerbo, John Hansen, Karen B. Jacobson, Lawrence Block, Thomas Duszynski, Colin Rogerson, Michelle Barron, Catia Chávez, Josephine Mak, Allison Avrich Ciesla, Monica Godfrey, Morgan Najdowski, Ruth Link-Gelles, Jennifer DeCuir, Amanda Payne, Inih J. Essien, Amber Kautz, Sarah Ball
|
JAMA Network
Verified
Interim Estimated Effectiveness of 2025-2026 COVID-19 Vaccines in Adults Using a Test-Negative Design Supplement 1. eTable 1. International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) used to define COVID-19-like illness eTable 2. International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) used to define underlying medical condition and immunocompromise status Supplement 2. Table 1.
Dashboards Are Trendy, Visible Components of Data Management in Public Health: Sustaining Their Use After the Pandemic Requires a Broader View
The COVID-19 pandemic highlighted significant deficiencies in the US public health system,1 especially data-management challenges faced by public health agencies. Many data elements that are now routinely reported and available publicly, such as intensive care unit bed availability, were not measured by public health before the pandemic.
Opinion: The U.S. is getting plenty of COVID-19 vaccines, but you still won’t have a normal summer
Outside the Box Published: Feb. 12, 2021 at 8:17 a.m. ET The goal remains herd immunity, and that means more than 242 million people vaccinated Agence France-Presse/Getty Images The light at the end of this dark COVID-19 tunnel is quickly getting brighter – but you still won’t have a normal summer. Even as efforts to distribute and administer the COVID vaccine accelerate, the U.S. is unlikely to achieve herd immunity until mid-September.
‘A little bit of dread’: Despite IU’s efforts, immunocompromised students are scared
Junior William Strum lived in his IU apartment for just more than a week. When Strum spent time outside, he saw crowds of people walking up and down Kirkwood Avenue and members of greek life not wearing masks and breaking COVID-19 rules. “I just packed up as much as I could from my apartment and I flew back to Dallas because I figured that it wasn't going to get better,” Strum said.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Thomas
Contact Thomas, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack